The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ISHARES INC CORE MSCI EMKT 46434G103 162,035 2,916,918 SH   SOLE   2,916,918 0 0
DUOLINGO INC CL A COM 26603R106 74,661 785,000 SH   SOLE   785,000 0 0
NEUBASE THERAPEUTICS INC COM 64132K102 1,766 939,412 SH   SOLE   939,412 0 0
PREDICTIVE ONCOLOGY INC COM NEW 74039M200 202 207,144 SH   SOLE   207,144 0 0
VERA THERAPEUTICS INC CL A 92337R101 377 16,060 SH   SOLE   16,060 0 0
INNSUITES HOSPITALITY TR SH BEN INT 457919108 31 10,000 SH   SOLE   10,000 0 0